A 2-Part Study to Assess Potential Metabolism-Based Drug-Drug Interactions of E2006 When Coadministered With Itraconazole, Rifampin, Midazolam, or Bupropion
PHASE1CompletedINTERVENTIONAL
Enrollment
106
Participants
Timeline
Start Date
February 28, 2014
Primary Completion Date
April 30, 2014
Study Completion Date
June 30, 2014
Conditions
Healthy Subjects
Interventions
DRUG
rifampin 600 mg
DRUG
itraconazole 200 mg
DRUG
midazolam 2 mg with bupropion 75 mg
DRUG
E2006
Trial Locations (1)
78744
PPD Development LLC, Austin
All Listed Sponsors
lead
Eisai Inc.
INDUSTRY
NCT02085967 - A 2-Part Study to Assess Potential Metabolism-Based Drug-Drug Interactions of E2006 When Coadministered With Itraconazole, Rifampin, Midazolam, or Bupropion | Biotech Hunter | Biotech Hunter